SCHEMBL28806344

SCHEMBL28806344

CC(C)(C)OC(=O)N1CCC(n2cc(-c3cccc(O)c3)cn2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 4/20 0.53
ABL1 P00519 1/20 0.52
EGFR P00533 1/20 0.52
SRC P12931 1/20 0.52
ABL2 P42684 1/20 0.52
TTK P33981 2/20 0.51
MAP3K7 O43318 1/20 0.49
TAB1 Q15750 1/20 0.49
GPR119 Q8TDV5 2/20 0.49
FGFR3 P22607 3/20 0.49
KDR P35968 3/20 0.49
FGFR1 P11362 2/20 0.49
FGFR2 P21802 2/20 0.49
FGFR4 P22455 2/20 0.49
FLT3 P36888 2/20 0.49
TNK2 Q07912 1/20 0.49
DDB1 Q16531 1/20 0.48
CRBN Q96SW2 1/20 0.48
LIPC P11150 1/20 0.48
CCNC P24863 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16899860 0.89 MET (0.52) METTTKGPR119FGFR3KDR
SCHEMBL1653749 0.88 TNK2 (0.56) METEGFRSRCGPR119FGFR3
SCHEMBL30701907 0.86 CCNC (0.51) METTTKGPR119FGFR3KDR
SCHEMBL16899801 0.84 MET (0.51) METTTKGPR119FGFR3KDR
SCHEMBL20280701 0.84 MET (0.52) METTTKGPR119FGFR3KDR
SCHEMBL15431560 0.84 GPR119 (0.55) METTTKGPR119FGFR3KDR
SCHEMBL16899750 0.83 MET (0.51) METTTKGPR119FGFR3KDR
SCHEMBL15416610 0.83 MET (0.53) METTTKGPR119FGFR3KDR
SCHEMBL16907836 0.83 MET (0.51) METTTKGPR119FGFR3KDR
SCHEMBL20135336 0.83 GPR119 (0.58) METTTKGPR119TNK2DDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4554936-A1 CRIZOTINIB ANALOGUES AS SHIP1 INHIBITORS USEFUL TO TREAT ALZHEINER'S DISEASES The Trustees of Indiana University (US) 2025-05-21 EP disclosed
WO-2024015759-A1 CRIZOTINIB ANALOGUES AS SHIP1 INHIBITORS USEFUL TO TREAT ALZHEINER'S DISEASES THE TRUSTEES OF INDIANA UNIVERSITY (US) 2024-01-18 WO disclosed
CN-103420906-A Novel tyrosine protein kinase inhibitor NANJING SANHOME PHARMACEUTICAL CO LTD 2013-12-04 CN disclosed